TROG Cancer Research
Members Login   CQMS Login


New Proposal applications are accepted for consideration at any time throught the year.

Four types of New Proposals are accepted by TROG:

  • Category A: An investigator-initiated new proposal which can be submitted by a full TROG member, which will be carried out under the auspices of TROG.
  • Category B: An existing trial or new trial concept submitted by a full TROG member on behalf of a international trials organisation and where TROG would fulfill the role of the ANZ sponsor. The trial is carried out under the joint auspices of TROG and the group concerned. 
  • Category C: A trial initiated and sponsored by another trials organisation and is for collaboration with TROG.
  • Category D: An investigator-initiated project or registry that involves data capture, data mining or secondary analysis.

Submission process:

  1. Complete the online New Proposal application
     - you can stop the survey at any time and return at a later date to complete it, a survey link and return code will be provided if requested
     - a word version of the application is avalible for download to aid in drafting the proposal 
  2. Ensure that any supporting documentation has been uploaded, if applicable
  3. Submit the form by clicking 'Submit' on the last page of the application
  4. Once a new proposal has been submitted, it will be forward to the TROG Operations Executive committee for initial review 
     - a member of the TROG trial development team will be in contact after the initial review. See the TROG Study Pathway for further details. 

If you have any questions regarding the application or the New Proposal Pathway please contact or +61 2 40143910.


For detailed information on the progression of trials through TROGs trial timeline please refer to the TROG Study Pathway and TROG Policy Statement TPS E3 Guidelines on the Policy statements page.



PLEASE NOTE: In addition to the above, TROG also provides other Fee-For-Services, such as Radiotherapy Quality Assurance, Trial Management etc. Please contact TROG CEO,, for further detials.  

Thank you to the 100+ trial sites who support our clinical trials worldwide.

Latest News

  • 12 Feb 2019

    a new clinical trial by trog cancer research has shown for the first time that a new radiotherapy technique produced greater survival rates in early stage inoperable lung cancer patients, compared to conventional radiation treatment. the trog 09.02 chisel study aimed to investigate if...

  • 29 Jan 2019

    results from australia’s and new zealand’s biggest cancer trial have identified the best treatment regime for men suffering from newly-diagnosed aggressive but localised prostate cancer. the radar study, run through trog cancer research, compared the use of hormone treatment (longer v...

  • 07 Aug 2018

    trog cancer research has been successful in being awarded a $1.5 million grant (2018-2020) under the cancer australia support for cancer clinical trials program. the funding from cancer australia provides essential infrastructure for trog to build our capacity to undertake cancer...

  • 07 Aug 2018

    the board of trog cancer research is pleased to announce the appointment of susan goode as the new trog chief executive officer. susan is formerly the centre manager for the hunter cancer research alliance at the university of newcastle. in this role, she was key player in a strate...

  • 16 May 2018

    the inaugural trog trek has raised more than $10,000 for trog's cancer clinical trials. the group of volunteers took on a five-day 50 kilometre trek in the spectacular bay of fires region in north east tasmania in march. each of the team members either held fundraising events or...

  • 16 May 2018

    p style="font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2; text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-style: initial; text-decoration-color: initial;word-spacing:0px">span style="font-size:11.0pt; font-family:">trog board presid...

  • 16 May 2018

    more than 270 people attended the trog 2018 annual scientific meeting (asm) in hobart, tasmania from 19-22 march. the asm was the 30th for trog and attendees included oncologists, radiation therapists, physicists, study coordinators and data managers. delegates heard from a host of...

  • 27 Feb 2018

    trog stalwart professor bryan burmeister is retiring from his position at princess alexandra hospital (pah) in brisbane. the highly respected radiation oncologist has worked in various positions with queensland health for 29 years. he has been at pah for the past 16 years. profe...

  • 06 Feb 2018

    with every millimetre counting in radiation therapy treatment, a new world first study developed in australia could eventually benefit cancer patients across the world. a new trog study called 'liver ablative radiotherapy with kim' or td 17.03 lark has received $583,000 from the ca...

  • 06 Feb 2018

    a new study investigating the use of cutting-edge stereotactic ablative _ radiotherapy (sabr) to treat patients with inoperable kidney cancer has been received $589,000 in funding from cancer australia. trog researcher, a/prof shankar siva, from the university of melbourne and the ...